Exp Clin Endocrinol Diabetes 2013; 121(08): 483-487
DOI: 10.1055/s-0033-1347248
© Georg Thieme Verlag KG Stuttgart · New York

Healthy Obese and Post Bariatric Patients – Metabolic and Vascular Patterns

C. Bachmayer
1   5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Germany
A. Lammert
1   5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Germany
T. Hasenberg
2   Surgical Department, Universitätsmedizin Mannheim, University of Heidelberg, Germany
H.-P. Hammes
1   5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

received 18 March 2013
first decision 08 May 2013

accepted 15 May 2013

Publication Date:
13 June 2013 (online)



Obesity and the metabolic syndrome (MetS) are associated with endothelial dysfunction (ED). An established method to determine ED is retinal vessel analysis. Obesity is associated with MetS, but obese patients not matching all criteria of the MetS and therefore defined as metabolically healthy obese subjects (MHOS) exist. Bariatric surgery may be an appropriate option to treat morbid obesity. The aim of this study was to compare MetS, MHOS and post bariatric patients in adipocytokine ­patterns and ED.


Arterio-venous ratio (AVR) and vessel diameters from retinal photographs (IMEDOS™), parameters of MetS (IDF) and obesity-associated factors (hsCRP, TNF, Il-6, MCP-1, sICAM, sVCAM, IGF-BP3, RBP 4 and adiponectin) were assessed in 51 obese patients with MetS, 20 obese patients without MetS and 21 patients pre and post bariatric surgery.


Bariatric surgery improved ED as reflected by AVR and venous diameters (p<0.05 for both). These improvements were associated with lower levels of fasting plasma glucose, insulin, HOMA-IR, LDL-C, triglycerides, cholesterol, hsCRP, sICAM, and higher levels of adiponectin and RBP4 (p<0.05 for each parameter). MHOS differed from MetS by neck circumference, fasting plasma glucose, HOMA-IR, triglycerides, HDL-C, sICAM, and adiponectin (p<0.05), but not by RRs, RRd, insulin, LDL-C, hsCRP, Il-6, TNF, MCP-1, sVCAM, RBP-4, IGF-BP3, and retinal ED.


These data indicate that improved insulin-sensitivity and reduced inflammatory mediators characterize the metabolic outcome of postbariatric patients in comparison to MHOS. Thus, MHOS characterizes an intermediate state between MetS and postbariatric patients.

  • References

  • 1 Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62-66
  • 2 Scaglione R, Di Chiara T, Cariello T et al. Visceral obesity and metabolic syndrome: two faces of the same medal?. Intern Emerg Med 2010; 5: 111-119
  • 3 Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880
  • 4 Wong TY, Islam FM, Klein R et al. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci 2006; 47: 2341-2350
  • 5 Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders. Trends in Endocrinology & Metabolism 2006; 17: 262-268
  • 6 Wong TY, Duncan BB, Golden SH et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 2004; 45: 2949-2954
  • 7 Ikram MK. Are Retinal Arteriolar or Venular Diameters Associated with Markers for Cardiovascular Disorders? The Rotterdam Study. Investigative Ophthalmology & Visual Science 2004; 45: 2129-2134
  • 8 Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645
  • 9 Kloting N, Fasshauer M, Dietrich A et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299: E506-E515
  • 10 Bluher M. The distinction of metabolically �healthy’ from �unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21: 38-43
  • 11 Bays HE, Laferrere B, Dixon J et al. Adiposopathy and bariatric surgery: is �sick fat’ a surgical disease?. Int J Clin Pract 2009; 63: 1285-1300
  • 12 Lammert A, Hasenberg T, Kraupner C et al. Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery. Obesity (Silver Spring) 2012; 20: 2262-2267
  • 13 Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
  • 14 Hubbard LD, Brothers RJ, King WN et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999; 106: 2269-2280
  • 15 Huang PL. eNOS, metabolic syndrome and cardiovascular disease. Trends in Endocrinology & Metabolism 2009; 20: 295-302
  • 16 Kerr SMP, Livingstone MBE, McCrorie TA et al. Endothelial dysfunction associated with obesity and the effect of weight loss interventions. Proceedings of the Nutrition Society 2011; 70: 418-425
  • 17 Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451
  • 18 Davignon J. Role of Endothelial Dysfunction in Atherosclerosis. Circulation 2004; 109: III-27-III-32
  • 19 Wang JJ, Liew G, Klein R et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 2007; 28: 1984-1992
  • 20 Wang JJ, Taylor B, Wong TY et al. Retinal vessel diameters and obesity: a population-based study in older persons. Obesity (Silver Spring) 2006; 14: 206-214
  • 21 Bays HE. “Sick fat,” metabolic disease, and atherosclerosis. Am J Med 2009; 122: S26-S37
  • 22 Lau DC, Dhillon B, Yan H et al. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031-H2041
  • 23 Athyros VG, Tziomalos K, Karagiannis A et al. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev. 2011
  • 24 Brethauer SA, Heneghan HM, Eldar S et al. Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc 2011; 25: 2650-2659
  • 25 Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-836
  • 26 Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2010; 9: 9
  • 27 Kloting N, Graham TE, Berndt J et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007; 6: 79-87
  • 28 Bajzova M, Kovacikova M, Vitkova M et al. Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity. Physiol Res 2008; 57: 927-934
  • 29 Takebayashi K, Sohma R, Aso Y et al. Effects of retinol binding protein-4 on vascular endothelial cells. Biochemical and Biophysical Research Communications 2011; 408: 58-64
  • 30 Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovascular Research 2010; 89: 516-524
  • 31 Nijhuis J, van Dielen FM, Fouraschen SM et al. Endothelial activation markers and their key regulators after restrictive bariatric surgery. Obesity (Silver Spring) 2007; 15: 1395-1399
  • 32 Mundi MS, Lorentz PA, Swain J et al. Moderate Physical Activity as Predictor of Weight Loss After Bariatric Surgery. Obes Surg. 2013
  • 33 Contreras JE, Santander C, Court I et al. Correlation Between Age and Weight Loss after Bariatric Surgery. Obes Surg. 2013
  • 34 Munkonda MN, Martin J, Poirier P et al. Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women. Nutr Diabetes 2012; 2: e41
  • 35 Friebe D, Neef M, Kratzsch J et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011; 54: 1200-1211